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Abstract
Background: Cognitive dysfunction is clearly recognized in bipolar patients, but the degree of impairment varies due to
methodological factors as well as heterogeneity in patient populations. The goal of this study was to evaluate cognitive
functioning in bipolar patients and to assess its association with depressive symptoms. Post hoc the relationship with
lifetime alcohol use disorder was explored.
Methodology/Principal Findings: The study included 110 bipolar patients and 75 healthy controls. Patients with severe
depressive symptoms, (hypo)manic symptoms and current severe alcohol use disorder were excluded. Diagnoses were
evaluated via the Mini-International Neuropsychiatric Interview. Cognitive functioning was measured in domains of
psychomotor speed, speed of information processing, attentional switching, verbal memory, visual memory, executive
functioning and an overall mean score. Severity of depression was assessed by the Inventory of Depressive
Symptomatology-self rating. Patients were euthymic (n=46) or with current mild (n=38) or moderate (n=26) depressive
symptoms. Cognitive impairment was found in 26% (z-score 2 or more above reference control group for at least one
domain) of patients, most prominent in executive functioning (effect size; ES 0.49) and speed of information processing (ES
0.47). Depressive symptoms were associated with dysfunction in psychomotor speed (adjusted beta 0.43; R
2 7%), speed of
information processing (adjusted beta 0.36; R
2 20%), attentional switching (adjusted beta 0.24; R
2 16%) and the mean score
(adjusted beta 0.23; R
2 24%), but not with verbal and visual memory and executive functioning. Depressive symptoms
explained 24% of the variance in the mean z-score of all 6 cognitive domains. Comorbid lifetime alcohol use (n=21) was not
associated with cognitive dysfunction.
Conclusions/Significance: Cognitive dysfunction in bipolar disorder is more severe in patients with depressive symptoms,
especially regarding speed and attention. Therefore, interpretation of cognitive functioning in patients with depressive
symptoms should be cautious. No association was found between cognitive functioning and lifetime comorbid alcohol use
disorder.
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Introduction
During mood episodes [1–3], as well in euthymic phases [4,5]
bipolar patients show cognitive impairment in several neuropsy-
chological domains. The degree of cognitive impairment varies
extensively across studies due to methodological factors as well as
the heterogeneity of illnesses and patient characteristics [3,4,6–11],
as commonly seen in daily clinical practice. Sometimes clinicians
may request for a neuropsychological assessment, since well-
known social and occupational problems in bipolar patients
[12–14] partly seem to be due to cognitive impairment [15–21].
An important, yet unanswered, question is how to interpret the
test results in the presence of mood symptoms or long standing
alcohol use. Research looking for putative cognitive endopheno-
types [6,8,22] explicitly rules out patients characterized by
commonly seen illness characteristics, and thereby limits the
generalizability of these study results; after all bipolar patients are
known to be euthymic for not more than 50% of time [23–25] and
many suffer from comorbid substance use disorders, mostly
alcohol misuse [26,27]. Also, no consensus is reached about the
most appropriate cognitive test battery that should be used or
about the most appropriate threshold value delineating impaired
from unimpaired cognitive functioning. Prior research in bipolar
patients mainly reported cognitive functioning in terms of group
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clinical practice, is the use of cut-off scores, highlighting the
heterogeneity within the patient samples. Although arbitrary, a test
result exceeding the mean of the reference group with more than 2
standard deviations is commonly considered to indicate impaired
cognition [21,28,29].
In the current study cognitive functioning in bipolar patients as
seen in daily clinical practice was evaluated. This was accom-
plished by including a relatively unselected group of bipolar
outpatients. The extent and kind of cognitive impairment
compared to healthy controls was assessed using an extensive
cognitive battery. Furthermore, the association of cognitive
functioning with severity of depressive symptoms was explored.
In a post hoc analysis we also explored the association of cognitive
functioning with lifetime alcohol use disorder. Results are
expressed in group means, as well as proportions cognitively
impaired.
Methods
Ethics Statement
This study was conducted according to the principles expressed in
the Declaration of Helsinki. The study was approved by the
Institutional Review Board of the University Medical Centre
Groningen (reference numbers METc2005.236 and METc2007.200).
All participants provided written informed consent for the collection
of data and subsequent analysis.
Participants
Recruitment of bipolar patients and healthy controls (age 18–
65 years) took place between October 2005 and December 2008.
General exclusion criteria were: mental retardation (IQ,70) or a
known systemic or neurological disease which could influence
cognitive functioning. Bipolar patients had to meet DSM-IV
criteria for bipolar I, II or not otherwise specified disorder,
confirmed by the Mini-International Neuropsychiatric Interview
(MINI) [30]. Mild to moderate depressive symptoms were
allowed, defined as a score of #38 points [31,32] on the 30
item-Inventory of Depressive Symptomatology-self rating (IDS-
SR) [33]. Patients with (hypo)manic symptoms, defined as .7
points on the Young Mania Rating Scale (YMRS) [34] were
excluded. Regarding alcohol use disorders, patients were only
excluded when they currently needed treatment in a specialized
setting. Controls were systematically interviewed to exclude
participants with any current or lifetime major psychiatric
disorder, which included alcohol and substance use disorder. In
addition, controls were excluded in case of a positive first degree
family history for these disorders.
After screening for inclusion and exclusion criteria, 191 out of
261 patients from the outpatient clinic for bipolar disorder of the
University Medical Centre Groningen were found eligible. No
informed consent was obtained from 71 patients, for the following
reasons: too busy (n=22), fear for instability due to tests (n=6) or
other unspecified reasons (n=43). Non-participants did not differ
from the final bipolar sample in age (t=1.32, p=0.19), education
level (t=1.48, p=0.14), gender (x
2=0.37, p=0.54) or subtype of
bipolar disorder (x
2=1.15, p=0.56). A total of 120 bipolar
patients were tested, but due to missing data (n=4) and an IDS-
SR score above 38 (n=6), the final sample consisted of 110
participants. A total of 75 healthy controls were recruited using
flyers in the university and hospital and by advertisements in a
local newspaper. Healthy controls received 15 Euros (approxi-
mately 19 US Dollars) after participation in this study.
Clinical Evaluation
All assessments and tests were uniformly performed by trained
psychologists. Lifetime and current attention deficit and hyperac-
tivity disorder, lifetime and current alcohol and other substance
use disorders, as well as current psychotic features were assessed
using the MINI. Illness characteristics were provided by the
clinician via the Questionnaire for Bipolar Disorder (QBP; an
adaption of the Enrolment Questionnaire as previously used in the
Stanley Foundation Bipolar Network) [35,36]. In case of mismatch
between MINI and QBP results, diagnoses were checked with the
treating clinician. Level of education was based on the Dutch
educational system which differentiates already after primary
school into different levels, ranging from 1: primary school up to 6:
PhD or higher degree obtained.
Neurocognitive Assessment
The composition of the cognitive test battery was based on
existing literature and experience with the target group in clinical
practice. The battery included seven cognitive domains, consisting
of nine different tests, yielding 16 outcome variables.
The domain ‘‘psychomotor speed’’ was derived from the
reaction time test of the Cambridge Neuropsychological Test
Automated Battery (CANTAB) system [37]. The corresponding
outcome variables in this study were the variables simple
movement time (in milliseconds) and five-choice movement time
(in milliseconds). For the domain ‘‘speed of information process-
ing’’ the Stroop Colour and Word Test (SCWT) [38] and the
reaction time test of the CANTAB system [37] were used for the
outcome variables Stroop time 1 (words; in seconds), Stroop time 2
(colours; in seconds), simple reaction time (in milliseconds) and
five-choice reaction time (in milliseconds). For the domain
‘‘attentional switching’’ the Continuous Performance Task, based
on research of Smid et al. [39] was used. After a one minute
practice session, two 5 minutes task-blocks (either CPT-Q or CPT-
HQ condition) were performed, in which 15% of the stimuli were
target stimuli demanding a response. A reliable score of attentional
switching was used as outcome variable, composed of the
difference score of hits in CPT-Q version minus hits in CPT-
HQ version. The domain ‘‘verbal memory’’ was derived from the
California Verbal Learning Test [40] for the outcome variables
CVLT-trial 1 to 5 (verbal learning) and CVLT-number of words
long term free recall. The Pattern Recognition Memory (PRM)
test of the CANTAB system [37] was used to create the domain
‘‘visual memory’’ by calculating the outcome variables PRM-
immediate correct numbers and PRM-delayed correct numbers.
The domain ‘‘cognitive flexibility/planning’’ was derived from the
Zoo map task as subtest from Behavioural Assessment of the
Dysexecutive Syndrome (BADS) [41] and Stockings of Cambridge
(SOC) test from the CANTAB system [37]. The outcome variables
were the sum score of the raw scores of part 1 and part 2 from the
Zoo map task, as well as the number of problems solved in
minimal moves from the SOC. For the domain ‘‘executive
functioning/working memory’’ the Spatial Working Memory
(SWM) test of the CANTAB system [37] and the SCWT [38]
were chosen to calculate the outcome variables of number of
SWM-between errors for 8-box problems, SWM Strategy
(counting number of times the subject begins a new search with
the same box) and interference score of the SCWT (seconds).
In addition, premorbid intelligence (IQ) was estimated with the
National Adult Reading Test (NART) [42]. Detailed descriptions
of the pen-and-paper measures are provided by Lezak et al. [43].
Robbins et al. [37] discussed the CANTAB tests. The total
cognitive test battery was administered within about 2K hours,
with one break if necessary.
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Differences between bipolar patients and healthy controls on
demographic variables were examined by means of indepen-
dent t-tests for continuous variables or chi-square tests for
categorical variables. All cognitive variables were assessed for
normal distribution. When variables in the controls were
normally distributed, the scores of controls and patients were
transformed into z-scores using the mean and standard
deviations of the control group. Otherwise, test scores were
transformed to approximate normality by quadratic or log
transformation. Higher scores indicated poorer cognition. To
correct for age difference between patients and controls age-
adjusted z-scores for the patients were calculated using linear
regression. Differences in age-corrected z-scores between
patients and controls were tested using unpaired t-tests. The
analyses went on with those cognitive tests that showed
statistically significant differences between patients and con-
trols. Cognitive domain scores were created by calculating the
mean z-value of the pertaining cognitive variables. In addition,
a mean score was created by averaging the z-scores of all six
domains. For each cognitive domain the effect size (ES) was
calculated as the difference between the mean age-corrected z-
scores of controls and bipolar patients. This measure of effect
size (Glass’s D) can be interpreted as a modified Cohen’s d, in
the sense that it is based on control group data only [44]. ES
were calculated for all cognitive domains and, if necessary,
additionally corrected for the potential confounders gender,
educational level and premorbid IQ using multiple linear
regression analyses.
To study the association of depressive symptoms with cognitive
functioning we performed linear regression analyses with the age-
corrected z-scores for cognition as the dependent variable, and
the IDS-SR total score and potential confounders gender,
education and IQ as the independent variables. The continuous
IDS-SR total score was divided by 13 and consequently the
beta’s reported are per 13 points on the IDS-SR. The choice of
13 points is essentially arbitrary but approximately corresponds
to shifting from the level of none (0–13) to mild (14–25) or from
mild to moderate (25–38) depressive symptoms [31,32]. We
supplied each beta with the R
2 (explained variance) as an
indicator of model fit. In addition to the analysis of depressive
symptoms as a continuum we analyzed depressive symptoms
categorized as euthymic, mild, or moderate depressive symp-
toms. The same approach was followed for lifetime alcohol use
disorder with the understanding that this variable was dichoto-
mous only (present/absent). The linear regression model
assumptions of normality, linearity and homoscedasticity were
assessed using residual plots.
In addition to analyses of cognitive function in terms of group
means, we analysed the proportions of cognitive impairment. To
this end cognitive impairment in a patient was defined as a z-score
of 2 or more above the reference control group for at least one
domain; this comes down to a 2.5% prevalence of cognitive
impairment per domain in the reference control group. As the
analyses of continuous scores as described above are associated
with optimal statistical power we refrained from additionally
testing these categorical data. Statistical significance was defined as
p,0.05, two sided, except for the reduction of the cognitive
battery in which the statistical significance was defined as p,0.25;
the use of this more liberal significance level is advocated during
screening of variables for inclusion in subsequent analyses using
univariable analyses [45]. All analyses were performed using
Statistical Package for the Social Sciences (SPSS) Version 16.0
[46].
Results
Sample Characteristics
Demographical and clinical characteristics of bipolar patients
and healthy controls were listed in Table 1. The study included 91
bipolar I patients (82.7%) and 19 bipolar II patients (17.3%).
Patients were on average 5 years older than controls (t=22.52,
p=0.01). Patients were euthymic (n=46; IDS-SR score ,14) or
known with mild (n=38; IDS-SR score 14–25) and moderate
(n=26; IDS-SR score 26–38) [31,32] depressive symptoms. More
than half of the patients never experienced psychotic features.
Only 3 patients (2.7%) were medication-free; most other patients
used 1 (52.7%, n=58) or 2 (30.9%, n=34) different psychotropic
drugs, mostly lithium (61.8%, n=68) and anticonvulsants (43.6%,
n=48), all in therapeutic dosages or with therapeutic plasma
levels. Lifetime alcohol use disorder was present in 19.1% (n=21)
of cases. Thirteen patients from this group were also known with a
current alcohol use disorder.
Selection of the Cognitive Test Battery
Two cognitive outcome variables were eliminated from the
battery, since they did not discriminate between healthy controls
and bipolar patients at an alpha of 0.25, namely the sum score of
raw score part 1 and part 2 from the Zoo map task (t=22.47,
p=0.49) and the number of problems solved in minimal moves
from the SOC (t=20.18, p=0.86), which together formed the
whole domain of cognitive flexibility/planning (see Table 2 for raw
Table 1. Characteristics of Participants.
Patients Controls Test
£ p
N=110 N=75
Age (yrs), mean (SD) 45.7 (10.7) 40.8 (14.4) 22.52 0.01
*
Female gender, n (%) 67 (60.9) 48 (64.0) 0.18 0.67
Premorbid IQ, mean (SD) 106.5 (9.2) 106.6 (9.9) 0.08 0.94
Education level (1–6), mean (SD) 3.6 (1.0) 3.7 (1.1) 0.53 0.60
Duration of illness (yrs), mean (SD) 20.8 (12.6) -
IDS-SR, mean (SD) 17.3 (10.0) -
YMRS, mean (SD) 0.5 (1.3) -
Lifetime psychotic features, n (%) 51 (46.4) -
Comorbidity, n (%)
Lifetime ADHD 1 (0.9) -
Lifetime alcohol use disorder 21 (19.1) -
Current alcohol use disorder 13 (11.8) -
Lifetime other substance use 6 (5.5) -
Current other substance use 0 (0) -
Type of medication, n (%)
$ -
Lithium 68 (61.8) -
Anticonvulsants
{ 48 (43.6) -
Antipsychotics 27 (24.5) -
Antidepressants 19 (17.3) -
Benzodiazepines 8 (7.3) -
*p,0.05
$3 patients were medication-free
{3 patients used 2 types of anticonvulsants
£x
2 tests were used for categorical data and the unpaired t-test was used for
continuous data
doi:10.1371/journal.pone.0013032.t001
Cognition in Bipolar Disorder
PLoS ONE | www.plosone.org 3 September 2010 | Volume 5 | Issue 9 | e13032neuropsychological test results and Table 3 for age-adjusted z-
scores). Thus, further results refer to the remaining 14 cognitive
outcome variables, covering six domains.
Extent and Kind of Cognitive Dysfunctions
Mean age-adjusted domain specific z-scores of patients were
significantly different from controls in the range of small effect
sizes (i.e. ES,0.5), with relatively large confidence intervals (see
Figure 1). In the total bipolar cohort, largest ES were found for
executive functioning/working memory and speed of information
processing. After further correction for gender, education and IQ,
results were similar.
A total of 29 bipolar patients (26.4%) were defined as cognitively
impaired. Except for visual memory, dysfunctions were present in
11.8% (n=13) of cases in the domain verbal memory, 10.9%
(n=12) in speed of information processing, 9.1% (n=10) in
attention, 8.2% (n=9) in executive functioning and 7.3% (n=8) in
psychomotor speed. Heterogeneity within the cognitively impaired
group was also illustrated by the number of impaired domains:
most frequently one (51.7%, n=15) or two (31.0%, n=9) domains
were impaired, and only in 17.3% (n=5) of cases in the range of 3
to 5 domains.
Association between Depressive Symptoms and
Cognitive Functioning
Data in Table 4 are beta’s, adjusted for age and additionally for
gender, education and IQ, since these corrections led to
substantial differences. The assumptions of linear regression
analysis were found to be sufficiently met. An increase of 13
points on the IDS-SR total score, approximately comparable with
an increase of one level of depression severity was modestly
associated with psychomotor speed, speed of information process-
ing, attentional switching and the mean score. The proportion
variance explained (R
2) ranged from 7 to 25% for the various
domains of cognitive functioning and 24% for the mean z-score of
all 6 cognitive domains.
To further illustrate the effect of depressive symptoms on
cognition, the data of the euthymic (n=46; IDS-SR score ,14)
and depressed (n=64; IDS-SR score .13) patients were added to
Figure 1. Expressed as proportion impaired, 13% (n=6) of
euthymic patients, 37% (n=14) of patients with mild depressive
symptoms and 35% (n=9) of patients with moderate depressive
symptoms could be defined as cognitively impaired.
Association between Lifetime Alcohol Use Disorder and
Cognitive Functioning
Data in Table 5 are beta’s, adjusted for age only, since further
correction for gender, education, IQ and additionally for
depressive symptoms led to similar results. The assumptions of
linear regression analysis were found to be sufficiently met.
Lifetime alcohol use disorder (n=21, 19.1%) in bipolar patients
was not associated with the mean value of all six domains (age-
adjusted beta 20.04, 95% confidence interval: 20.39; 0.31; R
2
0.00), nor with any of the separate cognitive domains.
Discussion
The results of the current study confirm a significant
impairment of cognitive functioning in bipolar disorder [2–6,8].
However, to our knowledge this is the first study which explicitly
evaluated the effect of the severity of depressive symptoms and
lifetime alcohol use disorder on different types of cognitive
Table 2. Raw Data of the Neuropsychological Tests from 110 Bipolar Patients and 75 Healthy Controls.
Cognitive variables Patients Controls
Mean sd Mean sd
Simple movement time (msec) 462.88 150.45 416.19 109.20
Five-choice movement time (msec) 428.13 134.33 385.30 101.33
Simple reaction time (msec) 367.47 111.08 327.67 72.77
Five-choice reaction time (msec) 386.97 97.06 344.83 57.66
Stroop time 1 (word; sec) 45.78 9.74 41.79 7.07
Stroop time 2 (colour; sec) 59.45 13.48 54.61 7.99
Difference CPT hitrate version Q minus HQ 0.05 0.07 0.03 0.07
CPT hitrate version Q (% correct) 0.99 0.03 0.99 0.06
CPT hitrate version HQ (% correct) 0.94 0.08 0.97 0.06
CVLT - verbal learning (total nr correct resp) 51.92 12.28 57.24 8.01
CVLT – long term free recall (nr correct resp) 11.65 3.36 13.15 2.31
PRM – number correct immediate 10.53 1.66 11.01 1.48
PRM – number correct delayed 9.20 2.05 10.04 1.71
SOC – problems solved in minimal moves (nr correct) 8.29 1.94 8.36 1.98
Zoo map task (total score) of BADS 12.99 3.80 13.72 3.29
SWM –between errors 8 boxes (nr correct resp) 22.38 12.75 14.69 12.04
SWM – strategy (efficiency score) 34.21 6.21 31.25 6.55
Stroop interference (difference rate; sec) 7.36 24.80 20.11 10.16
CPT: Continuous Performance Task; CVLT: Dutch version of California Verbal Learning Test; PRM: Pattern Recognition Memory; SWM: Spatial Working Memory; SOC:
Stockings of Cambridge; BADS: Behavioural Assessment of the Dysexecutive Syndrome; msec: milliseconds; nr: number; resp: responses; sd: standard deviation; sec:
seconds.
doi:10.1371/journal.pone.0013032.t002
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depressive symptoms were included. Compared to healthy controls
(and using a statistical cut off score) around 10% of euthymic
bipolar patients and more than one third of patients with mild or
moderate depressive symptoms were found to be cognitively
impaired.
During euthymia cognitive problems in domains of executive
functioning, verbal memory [4,5,8], as well as attention and
processing speed [4] are often present in bipolar patients. These
dysfunctions seem to be more prominent within an acute phase of
bipolar disorder [1–3,47,48]. This notion is supported by our
results, especially for the domain of cognitive speed. In the total
bipolar sample, including patients in the range from euthymic to
moderate depressive symptoms, diffuse results with smaller effect
sizes were found in all domains, except for the domain cognitive
flexibility/planning which did not discriminate between patients
and healthy controls.
Depressive symptoms were associated with dysfunctions in
psychomotor speed (adjusted beta 0.43; R
2 7%), speed of
information processing (adjusted beta 0.36; R
2 20%), attentional
switching (adjusted beta 0.24; R
2 16%) and the mean score
(adjusted beta 0.23; R
2 24%), but not with verbal and visual
memory and executive functioning. Nevertheless, depressive
symptoms explained a large proportion of the variance in some
of the cognitive domains, indicating that the effect is substantive.
To our knowledge, only one previous two-year follow up study by
Frasch et al. [49] reported the effect of mood symptoms on
cognitive functioning reporting effect sizes; within a depressed
cohort of patients with both unipolar and bipolar depression (total
n=62), they used three experimental tasks and indirectly reported
that depressive symptoms were associated with processing speed
instead of verbal memory. These findings are in line with our
results. Importantly, subclinical mood symptoms (e.g. Hamilton
depression scores ,8, comparable with IDS-SR scores ,14) have
been stated as serious confounders [50], but a recent meta-
regression did not show any impact of such low scores on any of
the reported cognitive measurements in euthymic bipolar patients
[6].
Another study goal was to evaluate the possible, largely
undetermined [51,52] effect of lifetime comorbid alcohol use
disorder on cognitive functioning. No (additional) effect of lifetime
alcohol use disorder was found in any of the tested domains. This
finding is in line with recently reported data by Sanchez-Moreno
et al. [53], who compared cognitive function of 30 bipolar patients
with and 35 without a lifetime history of strictly defined alcohol
abuse or dependency. Other prior studies are ambiguous, with
some authors suggesting an additional decline in cognitive
functioning in patients with comorbid substance use disorder
[54,55], while others did not find any relation at all [56–59]. In the
current study we focused on the effect of lifetime, instead of
current alcohol use disorder [11], because cognitive dysfunctions
can remain over more than 5 years in alcoholics who finally
stopped using of alcohol [60,61] and past exposures are often not
taken into account [22]. We also did not demonstrate an effect of
current alcohol use disorder on any of the cognitive domains.
These negative findings can be explained by the post hoc
condition, as a result of which we did not explicitly recruit
patients with and without lifetime alcohol use disorders. This
apparently resulted in relatively small numbers of patients with
lifetime (19.1%, n=21) and with current (11.8%, n=13) alcohol
use disorder. Another reason for these small numbers is that
patients with current severe alcohol use disorder were excluded.
Highlighting the heterogeneity of cognitive dysfunctions re-
vealed cognitive impairments in 26% of our patient cohort, mainly
in one variable domain. This result is difficult to compare with
prior research. For example, Gualtieri and Morgan [28] defined
five cognitive domains (memory, psychomotor speed, information
processing speed, attention and cognitive flexibility) based on
different tasks than the current study and without mood ratings. In
that study thirty percent of bipolar patients were considered
cognitively impaired, using 2 standard deviations below mean as
cut off score. Thompson et al. [62] evaluated the magnitude of
effect sizes in 11 individual cognitive tasks in euthymic bipolar
patients, with (arranged by the magnitude of effect sizes) 3–42% of
all patients being cognitively impaired. Iverson et al. [63]
calculated five domain scores based on fully computerized
cognitive tests (memory, psychomotor speed, reaction time,
cognitive flexibility, and complex attention), evaluating 47
outpatients with bipolar disorder derived from a sample of
convenience (no formal diagnostic interviewing or symptom rating
scales) and reported 47% of patients as cognitively impaired, using
one or more domain scores of 2 SD below the mean. Looking at
the number of impaired cognitive domains, Martino et al. [29]
stated that 38% of euthymic bipolar patients were not impaired in
any of the six domains (attention, verbal memory, language,
psychomotor speed, executive function and facial recognition task),
Table 3. Age-adjusted Cognitive Z-scores of 110 Bipolar
Patients.
Domains and pertaining variables Mean SD t test p
Psychomotor speed
Simple movement time
{ 0.33 1.3 21.84 0.07 *
Five-choice movement time
{ 0.32 1.3 21.88 0.06 *
Speed of information processing
Simple reaction time
{ 0.43 1.5 22.41 0.02 *
Five-choice reaction time
{ 0.55 1.6 23.06 0.00 *
Stroop time 1 (word)
{ 0.41 1.3 22.53 0.01 *
Stroop time 2 (colour)
{ 0.50 1.7 22.60 0.01 *
Attentional switching
Difference CPT hitrate version Q minus HQ
{ 0.30 1.0 22.06 0.04 *
Verbal memory
CVLT - verbal learning (total of trial 1–5)
{ 0.50 1.5 22.89 0.00 *
CVLT – long term free recall 0.34 1.0 22.19 0.03 *
Visual memory
PRM – number correct immediate 0.33 1.0 21.95 0.05 *
PRM – number correct delayed 0.41 1.0 22.71 0.01 *
Cognitive flexibility/planning
SOC – problems solved in minimal moves
{ 20.11 0.9 0.69 0.49
Zoo map task (total score) of BADS 0.04 1.1 20.14 0.89
Executive functioning/working memory
SWM –between errors 8 boxes 0.43 0.8 23.49 0.00 *
SWM – strategy
{ 0.30 0.8 22.32 0.02 *
Stroop interference
{ 0.73 2.4 22.83 0.01 *
Healthy controls (n=75) were used as reference score.
For all cognitive measures: higher values indicate worse performance.
*p,0.25.
{normally distributed
CPT: Continuous Performance Task; CVLT: Dutch version of California Verbal
Learning Test; PRM: Pattern Recognition Memory; SWM: Spatial Working
Memory; SOC: Stockings of Cambridge; BADS: Behavioural Assessment of the
Dysexecutive Syndrome.
doi:10.1371/journal.pone.0013032.t003
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short overview shows that consensus about how to test (which
domains, which tests) and how to define cognitive impairment is
urgently needed.
The current study has several strengths and limitations. A major
strength is the generalizability of test results. The study population
comprised 60% of the patients of our outpatient clinic for bipolar
disorders who fulfilled inclusion criteria other than informed
consent, while refusers were not found to be different form those
who gave consent on major demographic and illness character-
istics. Moreover, although our academic centre is specialized in the
treatment of bipolar patients, the majority of patients were not
referred for tertiary care or more specialized treatment indicated
by the fact that many patients receive only one or two types of
medication. Finally, the exclusion rate was very low; i.e. we
excluded only patients who were severely depressed or (hypo)-
manic, patients with severe current alcohol or drug abuse and
patients with a medical comorbidity known to affect cognitive
functioning. Therefore, these findings are considered representa-
tive for the population of bipolar patients as seen in clinical
practice. Also, since only one patient (0.9%) was diagnosed with
lifetime Attention Deficit Hyperactivity Disorder (ADHD), the
Figure 1. Cognitive Performance in the Total Group and Subgroups of Bipolar Patients. Total group (n=110; dots), the euthymic
subgroup (n=46; triangle) and depressed subgroup (n=64; square), with healthy controls (n=75) used as reference score. Values are effect sizes,
corrected for age. Error bars are 95% confidence intervals (95%CI). Statistical significance for group differences between bipolar patients and healthy
controls was defined as p,0.05, shown in the figure as 95%CI which does not cross the base-line. Statistical significance (p,0.05) of sub-group
differences were marked with an asterix (*) and were based on continuous depression scores. Speed = psychomotor speed; Process = speed of
information processing; Attention = attentional switching; Verbal = verbal memory; Visual = visual memory; Exec/WM = executive functioning/
working memory; Mean = mean z-score of all 6 cognitive domains.
doi:10.1371/journal.pone.0013032.g001
Table 4. Associations between Depressive Symptoms and
Cognitive Performance.
Beta
{ 95%CI R
2 p
Speed 0.43 0.12; 0.73 0.07 0.01 *
Process 0.36 0.07; 0.64 0.20 0.02 *
Attention 0.24 0.01; 0.47 0.16 0.04 *
Verbal 0.20 20.06; 0.47 0.25 0.13
Visual 0.09 20.11; 0.29 0.21 0.39
Exec/WM 0.04 20.23; 0.30 0.05 0.78
Mean 0.23 0.06; 0.39 0.24 0.01 *
For all cognitive measures: Beta’s are corrected for age, gender, education and
IQ. Higher values indicate worse performance.
*p,0.05.
95%CI: 95% confidence interval.
{All beta’s are regression coefficients indicating the mean change in cognitive
performance, associated with an increase of 13 points IDS-SR score.
R
2: explained variance.
Speed = psychomotor speed; Process = speed of information processing;
Attention = attentional switching; Verbal = verbal memory; Visual = visual
memory; Exec/WM = executive functioning/working memory; Mean = mean z-
score of all 6 cognitive domains.
doi:10.1371/journal.pone.0013032.t004
Table 5. Associations between Lifetime Alcohol Use Disorder
and Cognitive Performance.
Beta
{ 95%CI R
2 p
Speed 20.36 0.95; 0.22 0.01 0.22
Process 20.08 20.67; 0.51 0.00 0.79
Attention 0.12 20.34; 0.59 0.00 0.60
Verbal 0.40 20.17; 0.96 0.02 0.17
Visual 20.13 20.55; 0.30 0.00 0.55
Exec/WM 20.19 20.70; 0.32 0.01 0.47
Mean 20.04 20.39; 0.31 0.00 0.82
For all cognitive measures: Beta’s are corrected for age. Higher values indicate
worse performance.
*p,0.05
95%CI: 95% confidence interval
{All beta’s are regression coefficients indicating the change in cognitive
performance, associated with the presence of lifetime alcohol use disorder.
R
2: explained variance
Speed = psychomotor speed; Process = speed of information processing;
Attention = attentional switching; Verbal = verbal memory; Visual = visual
memory; Exec/WM = executive functioning/working memory; Mean = mean z-
score of all 6 cognitive domains.
doi:10.1371/journal.pone.0013032.t005
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[51], a factor often overlooked in cognitive literature. ADHD is
characterized by attention and executive problems in childhood
[64] and is reported in up to 16% of adult bipolar patients [65].
Importantly, psychiatric comorbidity (e.g. anxiety disorder) did not
seem to aggravate the level of cognitive dysfunction in depressed
young adults [56]. The cognitive test battery used in this study is
another major advantage, since it covers all relevant cognitive
domains with regard to bipolar disorder, but by averaging
different tasks within the corresponding domains, it reduces
multiple comparisons for data analysis and avoids disproportionate
emphasis of single test results [66]. Also, in this manner we
expanded the number of domains that have been evaluated in
depressed bipolar patients [2].
Some limitations need to be considered. In absence of
(hypo)manic patients, we can only make statements about the
association of depressive symptoms with cognitive functioning in
bipolar patients. Furthermore, this is a cross-sectional study and
therefore it does not allow drawing conclusions about the causality
between cognitive functioning and the two commonly seen patient
characteristics (depressive symptoms and lifetime alcohol use).
Although the current study sample was large compared to previous
studies in this area, it could have been too small to detect
significant results, especially regarding the comparison of sub-
groups, including the post hoc analysis of the potential effect of
lifetime alcohol use disorder. Therefore, future research should
formulate a specific aim to recruit sufficiently large samples of
patients from the various subgroups.
From a clinical perspective (instead of aetiological origin) we
choose to study a heterogeneous patient cohort. It has never been
the main focus to take into account all the possible influence of
medications and psychiatric comorbid conditions. Research in this
area [51,67] is still ongoing. For example, a recent meta-analysis
surprisingly showed that lithium treatment has only few and minor
negative effects on cognition [68]. Finally, it is tempting to define
the effect sizes of cognitive domains and effect sizes of the
association with patient characteristics in terms of small, moderate
or even large effect sizes, but since the lack of knowledge of clinical
relevance (instead of statistical significance) these magnitudes of
numbers have to be interpreted with caution. Also, it could be
argued that the cut off score of 2 standard deviations is relatively
conservative, but proven to detect significantly impaired persons.
In conclusion, our study confirmed and extended the knowledge
of cognitive dysfunction in patients with bipolar disorder.
Cognitive dysfunction is more severe in patients with depressive
symptoms, especially regarding the domains of speed and
attention. Therefore, assessment of cognitive functioning in
patients with mild to moderate depressive symptoms should be
interpreted with caution. Moreover, post hoc analysis did not show
any association between cognitive functioning and lifetime
comorbid alcohol use disorder.
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